Detected ·
Mahzi Therapeutics
——
Mahzi Therapeutics, a clinical-stage biotech developing gene therapies for rare neurodevelopmental disorders, launched a Regulation Crowdfunding round — allowing families affected by rare diseases to invest in the treatments. The company is also dosing patients in the first-ever gene therapy trial for Pitt Hopkins syndrome.
- Website
- —
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-20 16:08:28 UTC
- Signal ID
- ee60090a-e09c-4e31-bd5c-ee7a4692445e
As the API returns it
{
"id": "ee60090a-e09c-4e31-bd5c-ee7a4692445e",
"created_at": "2026-07-20T16:08:28.533509Z",
"company_name": "Mahzi Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Mahzi Therapeutics, a clinical-stage biotech developing gene therapies for rare neurodevelopmental disorders, launched a Regulation Crowdfunding round — allowing families affected by rare diseases to invest in the treatments. The company is also dosing patients in the first-ever gene therapy trial for Pitt Hopkins syndrome.*"
}